<DOC>
	<DOCNO>NCT00792558</DOCNO>
	<brief_summary>The purpose study find maximum tolerated dose BMS-817378 subject advance cancer</brief_summary>
	<brief_title>Ascending Multiple-Dose Study BMS-817378 Subjects With Advanced Cancers</brief_title>
	<detailed_description />
	<criteria>Confirmed diagnosis advance nonhematologic malignancy . Dose expansion cohort restrict subject advanced metastatic gastroesophageal cancer , squamous cell cancer head neck , castration resistant prostate cancer ECOG status 01 WOCBP unwilling/unable use acceptable contraception method , woman pregnant breast feed Symptomatic brain metastasis Uncontrolled significant cardiovascular disease History thromboembolic event bleed diathesis past 6 month Conditions require prophylactic anticoagulation chronic antiplatelet therapy Serious nonhealing wound , ulcer bone fracture past 3 month Hemorrhage bleed event &gt; = CTCAE grade 3 past 4 week Proteinuria &gt; = 2+ dipstick &gt; = 1gm/24 hour Concurrent chemotherapy , hormonal therapy , immunotherapy , radiation therapy therapy investigational product Concurrent herbal , alternative , food supplement , strong CYP 3A4 inhibitor inducer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>